Key result
Among patients with hip fractures treated with dextran prophylaxis, the preoperative prevalence of thromboembolic disease was 9% and the postoperative incidence was 11%.
Population
176 patients with hip fractures (femoral neck or intertrochanteric fractures)
Design
Cohort
Authors
Loading...
High preoperative/postoperative DVT rates despite dextran in hip fracture patients warrant caution; this Level 3 data leaves open optimal prevention strategies.
Cohort (n=176)
Hip fracture patients have a significant risk of preoperative and postoperative deep-venous thrombosis despite dextran prophylaxis, particularly in the injured extremity.
Roberts et al. (1990) conducted a cohort in Hip fractures (n=176). Hip fractures treated with dextran prophylaxis was evaluated on Preoperative prevalence and postoperative incidence of thromboembolic disease. Among patients with hip fractures treated with dextran prophylaxis, the preoperative prevalence of thromboembolic disease was 9% and the postoperative incidence was 11%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: